×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Placental Stem Cell Therapy Solution Market Demand By Manufacturers, Countries, Type and Application, Forecast to ...
openPR.com
Press release - INFINITY BUSINESS INSIGHTS - Placental Stem Cell Therapy Solution Market Demand By Manufacturers, Countries,...
5 hours ago
Options Traders Expect Huge Moves in Pluristem Therapeutics (PSTI) Stock
Yahoo Movies UK
Investors in Pluristem Therapeutics (PSTI) need to pay close attention to the stock based on moves in the options market lately.
1 week ago
Israel's cell-based coffee: Sustainable solution to brewing industry challenges?
The Jerusalem Post
Due to climate change, within the next two decades, there is an expected 50% reduction in areas suitable for growing coffee.
3 months ago
Pluri Inc (Pluristem Therapeutics) Holds No Hope For The Weak
Seeking Alpha
Summary · Pluri Inc, formerly Pluristem Therapeutics, is a biotechnology research company developing medical, pharma, and food products from...
15 months ago
Acute Respiratory Distress Syndrome Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Leading ...
GlobeNewswire
The acute respiratory distress syndrome market size shall grow during the forecast period (2023–2032) owing to the launch of upcoming...
7 months ago
Pluristem begins dosing with Covid-19 therapy in Israel
Clinical Trials Arena
Pluristem Therapeutics has started dosing Covid-19 patients in Israel with PLX cells under a compassionate use programme approved by health...
49 months ago
Israeli co Pluri launches cell-based coffee
Globes - Israel Business News
Compared with traditional methods of coffee production, Pluri's cell-based coffee is estimated to cut water usage by 98%.
3 months ago
Pluristem Up on Cell Therapy Treatment of Coronavirus Patient
Yahoo Movies Canada
Shares of Israel-based Pluristem Therapeutics Inc. PSTI grew 13.5% after it announced that it has treated its first patient suffering from...
3 weeks ago
Biotechnology Company Pluristem, and Israel's Largest Food Producer Tnuva, Launch Landmark Collaboration to ...
PR Newswire
Collaboration uniquely combines Pluristem's technological expertise in mass-scale, cost-effective, consistent cell production with Tnuva's...
27 months ago
Israeli placenta-derived cells get nod from top researchers
The Times of Israel
Pluristem's platform, which delivers a 'cocktail of therapeutic proteins,' is seen to be useful for a slew of diseases.
105 months ago